Award-winning actor and producer Sterling K. Brown joins Bristol-Myers Squibb in effort to share stories of What It's Like to Live with Cancer Today

Bristol-Myers SquibbTwo-time Emmy Award winner Sterling K. Brown (This Is Us, Black Panther) is partnering with Bristol-Myers Squibb on a series designed to illuminate the triumphs and challenges of life after a cancer diagnosis. Survivorship Today: What It's Like to Live with Cancer explores the stories of people who have experienced lasting physical, emotional and social effects from cancer to build greater understanding of, and draw attention to, survivorship-related issues.

Today, more people who have been diagnosed with cancer are able to live with the disease than ever before. During this time of rapid progress in cancer treatment, researchers are only just beginning to understand the long-term impacts of the disease on individuals and their loved ones. As the number of cancer survivors in the United States (U.S.) grows to nearly 17 million this year, it is increasingly important to recognize and address the current realities of cancer survivorship. Brown, who lost his uncle to cancer, is speaking with people around the country who have been impacted by the disease to find out what it's like to live with cancer today.

"When my uncle, Sonny, passed away from cancer just six months after his diagnosis, my entire family was devastated. Now, 15 years later, many people with cancer are living longer," said Brown. "While that means they might have a chance to celebrate another birthday or watch their children have children, it also means their lives have likely been forever changed. Survivorship Today will bring these experiences to light to show the long-term effects of cancer, with the goal of helping people feel supported every step of their journey."

Through the stories of people affected by cancer, the series will delve into topics such as:

  • Overcoming barriers: Some people who are diagnosed with cancer face a greater burden of the disease due to their unique circumstances, whether at home, at work or in their communities, which can affect them from diagnosis through treatment and beyond.
  • Impact on emotional and mental health: A person diagnosed with cancer is twice as likely to experience mental health problems compared to a person without the disease. These impacts can be even greater for individuals diagnosed as a young adult and can persist long after treatment ends.
  • Relationships afterward: Cancer touches all those who care about the person living with the disease. It deeply affects friends and family on emotional and physical levels as they do their best to support their loved one over time.

"Living long-term with cancer is a relatively new idea. We've made tremendous progress in addressing the disease itself, but we still need to answer the question of what comes next, outside of treatment," said Adam Lenkowsky, Head of U.S. Oncology, Bristol-Myers Squibb. "By bringing cancer survivorship into greater focus with this series, our goal is to help start a dialogue on the realities of living with cancer, so we can work together toward a day when all people with cancer can live longer, healthier lives and get the support they need."

Watch the series at SurvivorshipToday.com.

About Survivorship Today

Survivorship Today: What It's Like to Live with Cancer is an initiative by Bristol-Myers Squibb that, through the stories of people living with cancer, aims to advance our understanding of what it's like to live with the disease today and inspire action to provide better support.

About Cancer Survivorship

Cancer survivorship refers to the time from diagnosis throughout the remainder of a person’s life. There are nearly 17 million cancer survivors in the U.S. today. Over the next 10 years, this number is projected to increase to nearly 22 million. Today, more than 67 percent of people living with cancer have been alive for at least five years after their initial diagnosis, and more than 45 percent of people have been alive 10 years after diagnosis. However, many people living with cancer feel unprepared for life after active treatment.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Most Popular Now

AstraZeneca enters license agreement with KYM Bios…

AstraZeneca and KYM Biosciences Inc.* have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody drug conjugate (ADC) targetin...

Pfizer's elranatamab receives FDA and EMA filing a…

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the company's Biologics License Application (BLA) ...

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

Nanosatellite shows the way to RNA medicine of the…

The RNA molecule is commonly recognized as messenger between DNA and protein, but it can also be folded into intricate molecular machines. An example of a naturally occur...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

Engineered bacteria find tumors, then alert the au…

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of "bacterial suicide squad" that ...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...

AI conjures proteins that speed up chemical reacti…

For the first time, scientists have used machine learning to create brand-new enzymes, which are proteins that accelerate chemical reactions. This is an important step in...